 |
|
Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture
Susan E. Andrade, ScD;
Sumit R. Majumdar, MD, MPH;
K. Arnold Chan, MD, ScD;
Diana S. M. Buist, PhD;
Alan S. Go, MD;
Michael Goodman, PhD;
David H. Smith, PhD, MHA;
Richard Platt, MD, MS;
Jerry H. Gurwitz, MD
Arch Intern Med. 2003;163:2052-2057.
Background Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk of fracture, particularly for postmenopausal women with a history of fracture.
Methods A retrospective study was conducted using the automated databases of 7 health maintenance organizations to evaluate the use of drugs recommended for secondary prevention of osteoporotic fracture. Women 60 years and older with an inpatient or outpatient diagnostic code for a fracture of the hip, vertebra, or wrist between October 1, 1994, and September 30, 1996, and at least 1 year of continuous enrollment with a drug benefit plan following the date of fracture, were identified. The frequency of use of medications for the treatment of osteoporosis (estrogen replacement therapy, bisphosphonates, and calcitonin) during the 1-year period following the date of the initial fracture was estimated overall and according to patient age, fracture site, and year of fracture.
Results During the study period, 3492 women 60 years and older were diagnosed with a fracture of the hip, vertebra, or wrist, and met the inclusion criteria. Of these patients, 822 (24%) received a drug for osteoporosis treatment during the year following the fracture. The proportion of women receiving treatment for osteoporosis was approximately 2-fold higher among those with a fracture of the vertebra (44%) than among those with a fracture of the hip (21%) or wrist (23%) (P<.001). Of the 2605 women who had not been treated for osteoporosis in the 90 days before a fracture, 14% received treatment for osteoporosis in the year following a fracture. Increasing age was associated with a reduced likelihood of receiving osteoporosis treatment (P<.001).
Conclusions Most of the older women who had experienced a fracture of the hip, vertebra, or wrist did not receive drug treatment for osteoporosis within 1 year following the fracture. Interventions to improve the detection and treatment of osteoporosis in high-risk patients need to be developed.
From the Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester (Drs Andrade and Gurwitz); the Department of Medicine, University of Alberta, Edmonton, Alberta (Dr Majumdar); the Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, Mass (Drs Majumdar and Platt); the Channing Laboratory, Brigham and Women's Hospital, Boston (Drs Chan and Platt); the Department of Epidemiology, Harvard School of Public Health, Boston (Dr Chan); Harvard Pilgrim Health Care, Boston (Dr Platt); the Center for Health Studies, Group Health Cooperative, Seattle, Wash (Dr Buist); the Division of Research, Kaiser Permanente of Northern California, Oakland (Dr Go); HealthPartners Research Foundation, Minneapolis, Minn (Dr Goodman); Kaiser Permanente Northwest, Portland, Ore (Dr Smith); and the HMO Research Network Center for Education and Research in Therapeutics (Drs Andrade, Chan, Go, Goodman, Smith, Platt, and Gurwitz). The authors have no relevant financial interest in this article.
RELATED LETTER
Solutions to the Undertreatment of Osteoporosis-Related Fractures
Beatrice J. Edwards
Arch Intern Med. 2004;164(6):677.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Clinical Risk Factors for Fracture in Postmenopausal Osteoporotic Women: A Review of the Recent Literature
LaFleur et al.
The Annals of Pharmacotherapy 2008;42:375-386.
ABSTRACT
| FULL TEXT
Clinical Pharmacists' Role in Improving Osteoporosis Treatment Rates Among Elderly Patients with Untreated Atraumatic Fractures
Nadrash et al.
The Annals of Pharmacotherapy 2008;42:334-340.
ABSTRACT
| FULL TEXT
ASHP Therapeutic Position Statement on the Prevention and Treatment of Osteoporosis in Adults
MacLaughlin and Raehl
Am J Health Syst Pharm 2008;65:343-357.
FULL TEXT
Use of a Case Manager to Improve Osteoporosis Treatment After Hip Fracture: Results of a Randomized Controlled Trial
Majumdar et al.
Arch Intern Med 2007;167:2110-2115.
ABSTRACT
| FULL TEXT
Americans are not meeting current calcium recommendations
Ma et al.
Am. J. Clin. Nutr. 2007;85:1361-1366.
ABSTRACT
| FULL TEXT
Treatment and prevention practices in postmenopausal women after bone mineral density screening at a community-based osteoporosis project.
Rohr et al.
JAOA: Journal of the American Osteopathic Association 2006;106:396-401.
ABSTRACT
| FULL TEXT
Hip Fracture Risk Among Community-Dwelling Elderly People in the United States: A Prospective Study of Physical, Cognitive, and Socioeconomic Indicators
Wilson et al.
Am. J. Public Health 2006;96:1210-1218.
ABSTRACT
| FULL TEXT
How Can Osteoporosis Patients Benefit More from Their Therapy? Adherence Issues with Bisphosphonate Therapy
Gold et al.
The Annals of Pharmacotherapy 2006;40:1143-1150.
ABSTRACT
| FULL TEXT
Incidental Vertebral Fractures Discovered With Chest Radiography in the Emergency Department: Prevalence, Recognition, and Osteoporosis Management in a Cohort of Elderly Patients
Majumdar et al.
Arch Intern Med 2005;165:905-909.
ABSTRACT
| FULL TEXT
A Controlled Trial To Increase Detection and Treatment of Osteoporosis in Older Patients with a Wrist Fracture
Majumdar et al.
ANN INTERN MED 2004;141:366-373.
ABSTRACT
| FULL TEXT
Solutions to the Undertreatment of Osteoporosis-Related Fractures
Edwards
Arch Intern Med 2004;164:677-677.
FULL TEXT
Underreporting of Vertebral Fractures on Routine Chest Radiography
Kim et al.
Am. J. Roentgenol. 2004;182:297-300.
ABSTRACT
| FULL TEXT
|
